Mar 07, 2023 / 02:50PM GMT
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research Analyst
(technical difficulty) to the Cowen conference. Representing the company is Samit Hirawat, who is Executive Vice President and Chief Medical Officer and the Global Head of Drug Development. So thanks, Samit for making the time to be with us. Lots to talk about, lots going on in the Bristol pipeline. So we'll jump right in.
Questions and Answers:
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research AnalystLet's start with Sotyktu, which is off to just a terrific start in the marketplace for psoriasis. You're working on a number of other indications. Those are in development.
Can you kind of order them relative to your conviction and/or the market potential? And just remind us where those additional indications for Sotyktu stand today?
Samit Hirawat - Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Drug Development
Sure. Thanks, Steve, for the question. And